The Board of Anagenics Limited announced the intention of Mr. Dennis Eck to retire as a director following the completion of the Company's 2022 Annual General Meeting. Mr. Eck made a strategic investment in the company in December 2017 and has been a Non- Executive Director at Anagenics since March 2018. Dennis has been supportive of the continuing restructuring and repositioning of the Business and expresses his intention to continue as a supportive shareholder.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | +11.11% | +11.11% | -47.37% |
Mar. 08 | Anagenics Appoints CEO | MT |
Feb. 26 | Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.37% | 2.71M | |
+10.32% | 381B | |
+8.03% | 129B | |
-16.39% | 62.59B | |
+0.37% | 52.86B | |
-11.47% | 36.11B | |
+2.76% | 33.57B | |
+9.68% | 17.29B | |
+7.68% | 14.75B | |
-9.06% | 10.82B |
- Stock Market
- Equities
- AN1 Stock
- News Anagenics Limited
- Anagenics Limited Announces Resignation of Dennis Eck as Director